The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 756K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

11 articles for W Zeng


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Discovery and Assessment of Atropisomers of (±)-Lesinurad.EBI
Wuxi Apptec
Design, synthesis, anticancer activity and docking studies of novel 4-morpholino-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidine derivatives as mTOR inhibitors.EBI
TBA
Evaluation of aminohydantoins as a novel class of antimalarial agents.EBI
Saint Louis University
Short-acting T-type calcium channel antagonists significantly modify sleep architecture in rodents.EBI
TBA
Synthesis of 2-amino-5-benzoyl-4-(2-furyl)thiazoles as adenosine A(2A) receptor antagonists.EBI
Pharmacopeia
Indole-containing pharmaceuticals: targets, pharmacological activities, and SAR studies.EBI
Tianjin University
Design, synthesis, and biological evaluation of hederagenin derivatives with improved aqueous solubility and tumor resistance reversal activity.EBI
Yantai University
Small molecules inhibit the interaction of Nrf2 and the Keap1 Kelch domain through a non-covalent mechanism.EBI
Biogen Idec
Evaluation of 4-phenylamino-substituted naphthalene-1,2-diones as tubulin polymerization inhibitors.EBI
South China University of Technology
Discovery and optimization of selective FGFR4 inhibitors via scaffold hopping.EBI
Wuxi Apptec (Shanghai)
Bone marrow on X chromosome kinase (BMX) inhibitors and uses thereofBDB
Dana-Farber Cancer Institute